Related Experiment Video

Updated: May 27, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

ERα-dependent E2F transcription can mediate resistance to estrogen deprivation in human breast cancer

Todd W Miller1, Justin M Balko, Emily M Fox

  • 1Department of Cancer Biology, Breast Cancer Research Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, Tennessee 37232-6307, USA.

Cancer Discovery
|November 4, 2011
PubMed

Insights

Estrogen receptor alpha (ER) plays a role in hormone-independent breast cancer growth. Targeting ER, CDK4, and PI3K may overcome antiestrogen resistance.

Area of Science:

  • Oncology
  • Molecular Biology
  • Endocrinology

Background:

  • Estrogen receptor-positive (ER+) breast cancers often develop resistance to antiestrogen therapies.
  • Understanding the mechanisms of hormone-independent growth is crucial for improving treatment outcomes.

Purpose of the Study:

  • To investigate the role of ER and the CDK4/Rb/E2F axis in estrogen-independent breast cancer growth.
  • To identify potential therapeutic targets for overcoming antiestrogen resistance.

Main Methods:

  • Utilized ER downregulation with fulvestrant and siRNA.
  • Performed chromatin immunoprecipitation and gene expression profiling.
  • Conducted siRNA screening for CDK4 and tested combination therapies in xenografts.

Main Results:

  • ER downregulation inhibited estrogen-independent growth.
  • Identified an ER/E2F-directed transcriptional program active in hormone-deprived cells.
  • CDK4 is essential for estrogen-independent growth; PI3K pathway is hyperactivated.
  • Combination of fulvestrant and BKM120 induced xenograft regression.

Conclusions:

  • ER has an estrogen-independent role in breast cancer growth.
  • The CDK4/Rb/E2F axis is implicated in antiestrogen resistance.
  • Targeting ER, CDK4, and PI3K concurrently shows promise for treating resistant breast cancers.
Keywords:
CDK4Estrogen receptoraromatase inhibitorbreastresistance

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...